Pillstats
Rx only · Capsule · Oral

Palbociclib

Brands: Ibrance · Palbociclib

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers1 labelers
Packages3
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3206409601.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
906
Rx · 2026 Q1
19K
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 22, 2026
    RESOLVEDShortage resolved: Palbociclib Capsule (Pfizer Inc.)

    Palbociclib Capsule — reported in shortage by Pfizer Inc.. Therapeutic category: Oncology.

  • Apr 22, 2026
    SHORTAGEDrug shortage: Palbociclib Capsule (Pfizer Inc.)

    Palbociclib Capsule — reported in shortage by Pfizer Inc.. Therapeutic category: Oncology.